Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Curated Information Page
PubMed Id: 12881422 
Morton S, Davis RJ, McLaren A, Cohen P (2003) A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 22, 3876-86 12881422
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2012,40:D261-70). To learn more about the scope of PhosphoSitePlus®, click here.
Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.
Download Sites

S63-p - Jun (mouse)
Orthologous residues
Jun (human): S63‑p, Jun (mouse): S63‑p, Jun (rat): S63‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE JNK1 (mouse)
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE JNK1 (mouse) phospho-antibody, genetic knockout/knockin of upstream enzyme, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
KINASE ERK1 (mouse) phospho-antibody, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
SB203580, PD184352 LPS augment treatment-induced increase 10-15% increase
TNF increase
anisomycin increase
phorbol ester increase
PD184352 phorbol ester inhibit treatment-induced increase
EGF increase
PD184352 EGF inhibit treatment-induced increase

S73-p - Jun (mouse)
Orthologous residues
Jun (human): S73‑p, Jun (mouse): S73‑p, Jun (rat): S73‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE JNK1 (mouse)
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE ERK1 (mouse) phospho-antibody, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
KINASE JNK1 (mouse) phospho-antibody, genetic knockout/knockin of upstream enzyme, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
SB203580, PD184352 LPS augment treatment-induced increase 10-15% increase
TNF increase
anisomycin increase
phorbol ester increase
PD184352 phorbol ester inhibit treatment-induced increase
EGF increase
PD184352 EGF inhibit treatment-induced increase

T91-p - Jun (mouse)
Orthologous residues
Jun (human): T91‑p, Jun (mouse): T91‑p, Jun (rat): T91‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE JNK1 (mouse)
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE JNK1 (mouse) phospho-antibody, genetic knockout/knockin of upstream enzyme, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
SB203580, PD184352 LPS no effect upon treatment-induced increase
TNF increase
anisomycin increase

T93-p - Jun (mouse)
Orthologous residues
Jun (human): T93‑p, Jun (mouse): T93‑p, Jun (rat): T93‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE JNK1 (mouse)
Upstream Regulation
 Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE JNK1 (mouse) phospho-antibody, genetic knockout/knockin of upstream enzyme, pharmacological activator of upstream enzyme, pharmacological inhibitor of upstream enzyme
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS increase
SB203580, PD184352 LPS no effect upon treatment-induced increase
TNF increase
anisomycin increase

T242-p - Jun (mouse)
Orthologous residues
Jun (human): T239‑p, Jun (mouse): T242‑p, Jun (rat): T242‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE GSK3B (mouse)
Upstream Regulation
 Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
LPS decrease
wortmannin, PD184352 LPS no effect upon treatment-induced decrease
lithium decrease
EGF decrease
phorbol ester decrease
anisomycin decrease

S246-p - Jun (mouse)
Orthologous residues
Jun (human): S243‑p, Jun (mouse): S246‑p, Jun (rat): S246‑p
Characterization
 Methods used to characterize site in vivo phospho-antibody, western blotting
 Relevant cell lines - cell types - tissues:  MEF (fibroblast), RAW 264 (macrophage)
 Cellular systems studied:  cell lines
 Species studied:  mouse
 Enzymes shown to modify site in vitro
Type Enzyme
KINASE GSK3B (mouse)
KINASE ERK2 (mouse)


Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.